Determinants of Cardiovascular Disease Risk Factors Among Youth With Type 1 Diabetes
Launched by ST. JUSTINE'S HOSPITAL · Mar 9, 2020
Trial Information
Current as of May 22, 2025
Suspended
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of T1D (for the T1D group) or no diagnosis of any type of diabetes (for the control group)
- • 14 to 18 years old
- Exclusion Criteria:
- • Youth with another type of diabetes such as T2D
- • Conditions that could limit their ability to participate in the study
- • Known pathology that would influence their risk for CVD
- • Siblings of a participant already enrolled in the study
About St. Justine's Hospital
St. Justine's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research. Renowned for its commitment to excellence in patient care and medical education, the hospital serves as a vital center for clinical trials aimed at improving therapeutic options for children. With a multidisciplinary team of experts, St. Justine's Hospital leverages cutting-edge technology and evidence-based practices to facilitate groundbreaking studies that address a wide range of pediatric conditions, ensuring the highest standards of safety and efficacy for its young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montréal, Quebec, Canada
Patients applied
Trial Officials
Mélanie Henderson, MD, Ph.D
Principal Investigator
St. Justine's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials